# Who does Moderna pay? Who are its key suppliers?
Canonical: https://valuechain.wiki/moderna · Facet: suppliers · Updated: 2026-10-09T20:24:05.807+00:00 · Source: ValueChain.wiki (cited money-flow graph)

**Citable summary**: Moderna's confirmed suppliers/cost counterparties include Thermo Fisher Scientific, Danaher (Aldevron plasmid DNA) plus 2 undisclosed/aggregate relationships. Per the valuechain.wiki graph: 4 cost edges, backed by 7 dated sources, 1 of them primary filings (as of 2026-10-09).

### Lonza (mid)
- note: Lonza is a long-term contract manufacturer producing Moderna's COVID-19 vaccine material and potential follow-on products at U.S. and Swiss sites. Fees and actual purchase volumes under the 10-year agreement announced in 2020 were not disclosed.
- [confirms] Eugene Investment & Securities (KO, research, published 2026-01-19) https://www.eugenefn.com/common/files/amail/20260119_B3510_hskwon_315.pdf: "The report states that Lonza signed a 10-year agreement with Moderna in May 2020 to manufacture its COVID-19 vaccine and expanded capacity in the United States and Switzerland."
- [confirms] Lonza (EN, ir, published 2020-05-01) https://www.lonza.com/news/2020-05-01-04-50: "a 10-year strategic collaboration agreement to enable larger scale manufacture of Moderna's mRNA vaccine"

### 써모 피셔 사이언티픽 (mid)  → /thermo-fisher-scientific.md
- note: Thermo Fisher Scientific supplied raw materials and served as a manufacturing partner for aseptic fill-finish, labeling and packaging of Moderna's COVID-19 vaccine in North Carolina. The contract value was not disclosed.
- [confirms] Moderna (EN, ir, published 2021-06-01) https://s29.q4cdn.com/435878511/files/doc_news/2021/06/01/moderna-announces-agreement-thermo-fisher-scientific-fillfinish.pdf: "Thermo Fisher Scientific will provide fill/finish sterile manufacturing services, as well as labeling and packaging"

### Laboratorios Farmacéuticos ROVI (mid)
- note: ROVI participates in Moderna's supply chain by producing active substance in Granada and performing fill-finish work in Madrid. ROVI's 2024 materials confirmed an ongoing 10-year agreement covering COVID-19, RSV and influenza mRNA vaccines, but did not disclose its value.
- [confirms] ROVI (EN, ir, published 2024-11-07) https://www.rovi.es/sites/default/files/rovi_presentation_vf_0.pdf: "ROVI collaborates with Moderna in the end-to-end supply chain"

### 다나허 (알데브론 플라스미드 DNA) (mid)  → /danaher.md
- note: Moderna sources plasmid DNA, the starting material for mRNA vaccine production, from Danaher's Aldevron. The supply agreement was expanded in May 2021 to cover the COVID-19 vaccine and pipeline candidates. Payments are undisclosed.
- [mentions] U.S. SEC (EN, filing, published 2022-02-23) https://www.sec.gov/Archives/edgar/data/313616/000031361622000061/dhr-20211231.htm: "The Company... has expanded the business through numerous subsequent acquisitions, including... Cytiva in 2020 and Aldevron in 2021."
- [confirms] BioSpectator (KO, news, published 2021-06-18) https://m.biospectator.com/view/news_view.php?varAtcId=13444: "In May it also expanded its agreement to supply plasmid DNA to Moderna for COVID-19 vaccine production and further pipeline development. (Korean original, translated)"
- [confirms] Business Wire (EN, ir, published 2021-05-24) https://www.businesswire.com/news/home/20210524005254/en/Moderna-and-Aldevron-Announce-Expanded-Partnership-for-mRNA-Vaccine-and-Therapeutic-Pipeline: "Aldevron will provide plasmid DNA to serve as the genetic template for generating the COVID-19 mRNA vaccine and other investigational programs in Moderna's pipeline."

Reverse side: https://valuechain.wiki/moderna/customers.md · Ripple: https://valuechain.wiki/moderna/ripple.md

---
Full node: https://valuechain.wiki/moderna.md · JSON: https://valuechain.wiki/moderna.json